Target intelligence / Profile preview

Cyclin D1 (CCND1)

Target
CCND1
Molecular classification
Cyclin, Cell Cycle Regulator
01

Overview

Cyclin D1 is a regulatory protein that plays a central role in cell cycle progression, particularly in the transition from the G1 phase to the S phase. It acts as a regulatory subunit for cyclin-dependent kinases CDK4 and CDK6, forming active complexes that phosphorylate and inactivate members of the retinoblastoma (RB) protein family, including RB1. This phosphorylation releases E2F transcription factors, enabling transcription of genes required for DNA synthesis and entry into S phase. Overexpression of cyclin D1 is frequently observed across multiple tumor types, leading to unchecked proliferation due to loss of normal G₁/S checkpoint control. Cyclin D1 also regulates activity of various transcription factors, coactivators, corepressors involved in chromatin remodeling and histone acetylation, often via both CDK-dependent and independent mechanisms.

Other names
BCL1PRAD1
02

Mechanism of action

Inhibition of CDK4/6 kinase activity, leading to cell cycle arrest in G1 phase

03

Biological functions

Cell cycle progressionG1/S transitionTranscriptional regulationMetabolism regulationCellular migrationCell adhesion
04

Disease associations

CancerParathyroid adenomaBreast cancerColon cancerLymphoma (mantle cell lymphoma)MelanomaProstate cancer
05

Safety considerations

Potential for drug resistanceHematological toxicities (neutropenia, thrombocytopenia, anemia)FatigueDiarrhea
06

Interacting drugs

CDK4/6 inhibitors (e.g., Palbociclib, Ribociclib, Abemaciclib)
07

Biomarkers

Cyclin D1 expression level (IHC)CCND1 gene amplification

Beyond the preview

Go deeper on Cyclin D1 (CCND1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin D1 (CCND1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call